Related Experiment Video

Updated: Jul 10, 2026

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
12:44

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

Published on: November 11, 2014

EHA scientific workshop report: the role of epigenetics in hematological malignancies

Edgar Jost1, Oliver Galm

  • 1Medizinische Klinik IV, Universitaetsklinikum Aachen, RWTH Aachen, Aachen, Germany.

Epigenetics
|October 30, 2007
PubMed

Insights

Targeting cancer cell epigenetics via demethylation and histone acetylation offers a novel therapeutic strategy. This approach manipulates gene expression for advanced anti-cancer treatments, particularly in hematological malignancies.

Area of Science:

  • Oncology
  • Epigenetics
  • Pharmacology

Background:

  • Epigenetic modifications, including DNA methylation and histone acetylation, play a crucial role in cancer development.
  • Targeting the epigenome represents a promising new avenue for anti-cancer therapy.
  • Hematological malignancies are a key focus for epigenetic research.

Purpose of the Study:

  • To summarize key findings from a 2007 workshop on epigenetics in hematological malignancies.
  • To highlight recent advances in understanding the epigenome's role in tumorigenesis.
  • To outline future directions for basic, translational, and clinical research in cancer epigenetics.

Main Methods:

  • Discussion of fundamental aspects of DNA methylation and the histone code.
  • Review of chromatin remodeling and transcriptional regulatory mechanisms.
  • Consideration of recent technological advancements in epigenomic research.

Main Results:

  • Significant insights into altered epigenomes during tumorigenesis.
  • Identification of numerous opportunities for translational research.
  • Consensus on the potential of epigenetic therapies in oncology.

Conclusions:

  • Epigenetic targeting offers a novel pharmacologic concept for treating malignant diseases.
  • Further research is needed to translate epigenetic discoveries into effective clinical applications.
  • Collaboration between basic scientists and clinicians is essential for advancing epigenetic cancer therapy.

More Related Videos

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues10:41

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues

Published on: April 5, 2018

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...